A | Ampere |
A (in chemical element symbol) |
Mass Number |
A7R | Ala-Thr-Trp-Leu-Pro-Pro-Arg |
AAZTA | 2,2-((1,4-Bis(carboxymethyl)-1,4-diazepan-6-yl)azanediyl)diacetic Acid |
Ah | Ampere-hour |
BN | Bombesin |
Bq | Becquerel |
cRGD | Cyclic Arginylglycylaspartic Acid |
CT | Computed Tomography |
D | Deuteron |
DGA | Diglycolamide |
DO3AM-NI | 2,2′,2″-(10-(2-((2-(2-Nitro-1H-imidazol-1-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic Acid |
DO3AP | 2,2′,2″-(10-(Phosphonomethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic Acid |
DO3APABn | 2,2′,2″-(10-(((4-Aminobenzyl)(hydroxy)phosphoryl)methyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic Acid |
DO3APPrA | 2,2′,2″-(10-(((2-Carboxyethyl)(hydroxy)phosphoryl)methyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic Acid |
DOTA | 2,2′,2″,2‴-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic Acid |
DOTA-NOC | 2,2′,2″-(10-(2-((1-((13-((1H-Indol-3-yl)methyl)-10-(4-aminobutyl)-4-((1,3-dihydroxybutan-2-yl)carbamoyl)-7-(1-hydroxyethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic Acid |
DOTA-PSMA-617 | ((1-Carboxy-5-(3-(naphthalen-2-yl)-2-(4-((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl)cyclohexane-1-carboxamido)propanamido)pentyl)carbamoyl)glutamic Acid |
DOTA-RGD | 2,2′,2″-(10-(2-((4-(14-Benzyl-11-(carboxymethyl)-5-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)butyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic Acid |
DOTATOC | 2,2′,2″-(10-(2-((1-((13-((1H-Indol-3-yl)methyl)-10-(4-aminobutyl)-4-((1,3-dihydroxybutan-2-yl)carbamoyl)-16-(4-hydroxybenzyl)-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic Acid |
DR7A | DArg-DPro-DPro-DLeu-DTrp-DThr-DAla |
DTPA | 2,2′,2″,2‴-((((Carboxymethyl)azanediyl)bis(ethane-2,1-diyl))bis(azanetriyl))tetraacetic Acid |
E | Energy of an Incident Photon in a Scintillator |
e− | Electron |
e+ | Positron |
EDTA | 2,2′,2″,2‴-(Ethane-1,2-diylbis(azanetriyl))tetraacetic Acid |
ELISA | Enzyme-Linked Immunosorbent Assay |
eV | Electron Volt |
FISRE | Free-Ion Selective Radiotracer Extraction |
g | Ground State |
GRPR | Gastrin Releasing Peptide Receptors |
H3mpatcn | 2,2′-(7-((6-Carboxypyridin-2-yl)methyl)-1,4,7-triazonane-1,4-diyl)diacetic Acid |
H3NOTA | 1,4,7-Triazacyclononane-1,4,7-triacetic Acid |
H4pypa | 6,6′-(((Pyridine-2,6-diylbis(methylene))bis((carboxymethyl)azanediyl))bis(methylene))dipicolinic Acid |
HDEHP | Di-2-ethylhexyl Phosphoric Acid |
HFIR | High Flux Isotope Reactor |
HPGe | High-Purity Germanium |
HPLC | High Performance Liquid Chromatography |
ID/g | Injected Dose per Gram of Radionuclide |
iTLC | Instant Thin-Layer Chromatography |
K4R | Lys(HArg)-Dab-Pro-Arg |
LNCaP | Human Prostate Cancer Cell Line |
log K | Stability Constant |
log Ki | Protonation Constant |
m | Metastable State |
MBq/μmol | Megabecquerel per Micromole or Apparent Molar Activity |
MCi | Millicurie |
MP-AES | Microwave Plasma-Atomic Emission Spectrometry |
MRI | Magnetic Resonance Imaging |
N | Number of Neutrons |
nat-V | Natural Vanadium |
NBD | 2,2′,2″,2‴-(2-(4-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic Acid |
NI | 2-Nitroimidazole |
NODAGA-NOC | 2,2′-(7-(4-((1-((13-((1H-Indol-3-yl)methyl)-10-(4-aminobutyl)-4-((1,3-dihydroxybutan-2-yl)carbamoyl)-7-(1-hydroxyethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-carboxy-4-oxobutyl)-1,4,7-triazonane-1,4-diyl)diacetic Acid |
NODAGA-RGD | 2,2-(7-(1-Carboxy-4-((4-(11-(carboxymethyl)-5-(3-guanidinopropyl)-14-(4-hydroxybenzyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)butyl)amino)-4-oxobutyl)-1,4,7-triazonane-1,4-diyl)diacetic Acid |
NOTA | 2,2′,2″-(1,4,7-Triazonane-1,4,7-triyl)triacetic Acid |
NRP-1 protein | Neuropilin-1 Protein |
p | Proton |
PC-3 cells | Prostate Cancer cells |
PET | Positron Emission Tomography |
picagaDUPA | 17-(4-(Carboxymethyl)-7-((6-carboxypyridin-2-yl)methyl)-1,4,7-triazonan-1-yl)-5,10,14-trioxo-4,6,11,13-tetraazaheptadecane-1,3,7,17-tetracarboxylic Acid |
PSI | Paul Scherrer Institute |
PSMA | Prostate-Specific Membrane Antigen |
PTFE | Polytetrafluoroethylene |
RGD | Arg-Gly-Asp or Arginylglycylaspartic Acid |
s | Seconds |
SCID | Severe Combined Immunodeficiency Disease |
SCX | Strong Cation Exchange |
SEM | Scanning Electron Microscopy |
SiPM | Silicon Photomultiplier |
SPECT | Single-Photon Emission Computed Tomography |
SPION | Super-Paramagnetic Iron Oxide Nanoparticles |
t1/2 | Half-life |
TBP | Tributyl Phosphate |
TEM | Transmission Electron Microscopy |
TETA | 2,2′,2″,2‴-(1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetrayl)tetraacetic Acid |
TLC | Thin-Layer Chromatography |
UTEVA | Uranium and Tetravalent Actinide |
UV | Ultraviolet |
V/M | Volume-to-Muscle ratio |
VECC | Variable Energy Cyclotron Center |
x | Alpha or Beta Particle |
X | Position of an Incident Photon in a Scintillator on X-Axis |
X (in nuclear decay reactions) | Parent Nucleus |
X* | Excited Nuclear State of Parent Nucleus |
Y | Position of an Incident Photon in a Scintillator on Y-Axis |
Υ (in nuclear decay reactions) | Daughter Nucleus |
y | Years |
Z | Atomic Number |
α | Alpha Particle |
β | Beta Particle |
β+ | Positron |
γ | Gamma Radiation |
μL | Microliters |